These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2870639)

  • 21. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is tofisopam an atypical anxiolytic?
    Pellow S; File SE
    Neurosci Biobehav Rev; 1986; 10(2):221-7. PubMed ID: 2874535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.
    VanderMaelen CP; Matheson GK; Wilderman RC; Patterson LA
    Eur J Pharmacol; 1986 Sep; 129(1-2):123-30. PubMed ID: 2876903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".
    Uhlenhuth EH
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiolytic profiles.
    Gershon S; Eison AS
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin-1A anxiolytics: an overview.
    Feighner JP; Boyer WF
    Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments in 5HT-related pharmacology of animal models of anxiety.
    Gardner CR
    Pharmacol Biochem Behav; 1986 May; 24(5):1479-85. PubMed ID: 2873594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol.
    Gebauer DL; Pagnussat N; Piato AL; Schaefer IC; Bonan CD; Lara DR
    Pharmacol Biochem Behav; 2011 Sep; 99(3):480-6. PubMed ID: 21570997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological effects of buspirone.
    Lader M
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):62-8. PubMed ID: 6130075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of buspirone and alcohol on psychomotor skills.
    Mattila MJ; Aranko K; Seppala T
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):56-61. PubMed ID: 6130074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chronically administered buspirone and diazepam on driving-related skills performance.
    Moskowitz H; Smiley A
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):45-55. PubMed ID: 6130073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notes on buspirone's mechanisms of action.
    Garattini S; Caccia S; Mennini T
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coeruleus unit activity.
    Sanghera MK; German DC
    J Neural Transm; 1983; 57(4):267-79. PubMed ID: 6140300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buspirone, a new approach to the treatment of anxiety.
    Taylor DP
    FASEB J; 1988 Jun; 2(9):2445-52. PubMed ID: 2836252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buspirone, Parkinson's disease, and the locus ceruleus.
    Ludwig CL; Weinberger DR; Bruno G; Gillespie M; Bakker K; LeWitt PA; Chase TN
    Clin Neuropharmacol; 1986; 9(4):373-8. PubMed ID: 2873889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity.
    Sanghera MK; McMillen BA; German DC
    Eur J Pharmacol; 1982 Dec; 86(1):107-10. PubMed ID: 6130954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The serotonin- and dopaminergic mechanisms in the action of 1-pyrimidinyl piperazine derivatives].
    Abramets II; Obraztsova OG; Samoĭlovich IM; Kharin NA
    Eksp Klin Farmakol; 1992; 55(3):8-11. PubMed ID: 1360856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5HT neurons.
    Mennini T; Gobbi M; Ponzio F; Garattini S
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):40-9. PubMed ID: 2421657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings.
    Hjorth S; Carlsson A
    Eur J Pharmacol; 1982 Sep; 83(3-4):299-303. PubMed ID: 6129148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.